Key drivers shaping this market include technological shifts toward biocompatible, anti-thrombogenic coatings and the integration of AI-assisted navigation systems. Regulatory frameworks, such as FDA 510(k) clearances, continue to standardize product quality, while supply-chain dynamics are evolving to address global shortages of raw materials. North America dominates the market, accounting for ~42% of revenue in 2025, due to advanced healthcare infrastructure and high adoption rates. Meanwhile, Asia-Pacific is the fastest-growing region, fueled by expanding medical tourism, government-funded healthcare initiatives, and a rising geriatric population. Competitive intensity remains high, with manufacturers prioritizing R&D for hybrid hydrophobic-hydrophilic coatings to address unmet clinical needs.